Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics
The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.
Risk factors of misuse as well as diagnostic tools were identified.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.
Risk factors of misuse as well as diagnostic tools were identified. The objectives of our research are to determine the characteristics of the individuals suffering from an addiction to analgesics of level 2 followed in consultation of addictology in the hospital of Montpellier and Nimes and to describe the type of follow-up proposed to the patients in these two centers. It is a retrospective and descriptive study.
As part of this research, we will solicit all the patients followed in consultation of addictology or in hospitalization to the hospital of Montpellier or Nîmes for an addiction to the analgesics of grade 2 between the 1st of January 2014 and the 10th of July 2017 with requests of management for withdrawal or reduction of doses, opioid analgesics in the absence of pain or in chronic non-cancer pain, opioid analgesics to avoid withdrawal syndrome or hyperalgesia and consumptions chronic to dosages inadequate to the functional complaint evaluated by the rhumatology or algology services.
The data are collected in the medical file at the two participating institutions (Montpellier and Nîmes) and if necessary, patients not seen in consultation for more than 6 months will be recontacted.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Montpellier, Frankrig, 34295
- Uhmontpellier
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Requests for management for weaning or reduction of doses
- Take opioid analgesics in the absence of pain or as part of chronic non-cancer pain
- Opioid analgesics to prevent withdrawal syndrome or hyperalgesia
- Chronic consumption at inadequate dosages compared to the functional complaint evaluated by the MPR / Algologie services
- Patients over 18 years and who agree with the study
Exclusion criteria:
- language barrier
- severe cognitive and / or psychiatric disorders
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
50/5000 Prevalence of demand for care in addictology
Tidsramme: 1 day
|
Prevalence of demand for addictive care in subjects with addiction to analgesics in level 2
|
1 day
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Types of support proposed
Tidsramme: 1 day
|
Types of support proposed
|
1 day
|
|
Assessment of analgesic dependence
Tidsramme: 1 day
|
Assessment of analgesic dependence
|
1 day
|
|
History of analgesic use
Tidsramme: 1 day
|
History of analgesic use
|
1 day
|
|
quality of life
Tidsramme: 1 day
|
quality of life
|
1 day
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: TARUFFI Floriane, Doctor, University Hospital, Montpellier
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RECHMPL17_0305
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Analgesics Grade 2's Addiction
-
University of LahoreAfsluttetAnkelforstuvning 1. grad | Ankelforstuvning 2. grad | Lateral ankelforstuvningPakistan
-
Peking Union Medical College HospitalIkke rekrutterer endnuCervikal intraepitelial neoplasi grad 2 (CIN2)
-
Decathlon SEEFOR, FranceAfsluttetAnkelforstuvning 1. grad | Ankelforstuvning 2. grad | Ankelforstuvning 3. gradFrankrig
-
National Defense Medical Center, TaiwanTri-Service General HospitalRekrutteringAnkelforstuvning 2. grad | Ankelforstuvning 3. gradTaiwan
-
Instituto Mexicano del Seguro SocialAfsluttetAnkelforstuvning | Ankelforstuvning 1. grad | Ankelforstuvning 2. gradMexico
-
KeriCure MedicalThe University of Texas Health Science Center at San Antonio; Valleywise... og andre samarbejdspartnereRekruttering
-
Université Catholique de LouvainAfsluttetAnkelforstuvning 1. grad | Ankelforstuvning 2. gradBelgien
-
National Cancer Institute (NCI)AfsluttetStadie III grad 1 follikulært lymfom | Stadie III grad 2 follikulært lymfom | Stadie III grad 3 follikulært lymfom | Fase IV Grad 1 follikulært lymfom | Stadie IV Grad 2 follikulært lymfom | Stadie IV Grad 3 follikulært lymfomForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutteringTilbagevendende grad 1 follikulært lymfom | Tilbagevendende grad 2 follikulært lymfom | Tilbagevendende grad 3a follikulært lymfom | Refraktær grad 1 follikulært lymfom | Refraktær grad 2 follikulært lymfom | Refraktær grad 3a follikulært lymfomForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspenderetTilbagevendende grad 1 follikulært lymfom | Tilbagevendende grad 2 follikulært lymfom | Tilbagevendende grad 3a follikulært lymfom | Refraktær grad 1 follikulært lymfom | Refraktær grad 2 follikulært lymfom | Refraktær grad 3a follikulært lymfomForenede Stater